Replies to post #57449 on Options Wonderland

[3xBuBu]

I have the same feeling that
it is a summer rally since it broke the strong resistance @1040 triple bottom within this year
110 is current target

[3xBuBu]

First of three new obesity drugs up for review July 15

Vivus Inc (VVUS), Arena Pharmaceuticals Inc (ARNA) and Orexigen Therapeutics Inc (OREX) are trying to succeed where earlier efforts flopped after several weight-loss drugs were linked to serious side effects.

* VVUS-Vivus' Qnexa targets patients with related health issues

* ARNA-Arena, Orexigen seeking to sell rival drugs

* OREX-Orexigen has said the FDA will hold a Dec. 7 public review of its candidate, Contrave.

http://www.reuters.com/article/idUSN0821918620100708

[3xBuBu]

other pharma on radar
ARIA PPHM REGN